Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

Explore how Raman spectroscopy supports quantitative pharmaceutical analysis by enabling accurate measurement of active ...

BARCELONA, Spain—(UPDATED) Aspirin has long been the antiplatelet of choice for long-term secondary prevention in patients with coronary disease, but a meta-analysis of several trials suggests P2Y12 ...

Sophia Antipolis, 23 November 2021: Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin had an association with reduced cancer risk among older adults with clonal hematopoiesis.